Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,784
Total Claims
$724K
Drug Cost
417
Beneficiaries
$1,737
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-77%
Opioid rate vs peers
0.9% vs 3.8% avg
+48%
Cost per patient vs peers
$1,737 vs $1,174 avg
+39%
Brand preference vs peers
12.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.9%
Opioid Rate
75
Opioid Claims
$1,343
Opioid Cost
14.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,069 claims · $584K
Generic: 7,630 claims · $137K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 74 | $95K |
| Sitagliptin Phosphate | 91 | $75K |
| Apixaban | 66 | $59K |
| Dulaglutide | 23 | $33K |
| Linaclotide | 36 | $33K |
| Empagliflozin | 28 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $28K |
| Budesonide/Formoterol Fumarate | 33 | $20K |
| Fluticasone/Umeclidin/Vilanter | 20 | $18K |
| Rivaroxaban | 14 | $17K |
| Linagliptin | 21 | $15K |
| Dapagliflozin Propanediol | 13 | $11K |
| Insulin Detemir | 16 | $8,017 |
| Ipratropium/Albuterol Sulfate | 14 | $6,986 |
| Mirabegron | 13 | $6,799 |
Prescribing Profile
Patient Profile
72
Avg Age
72%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data